Glimpse Group, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Glimpse Group, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Jun 30, 2022 | $1.40M | Sep 28, 2022 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $10.53M | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | $8.80M | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | $13.48M | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $7.27M | Sep 29, 2023 |
| FY2022 | Jun 30, 2021 | $3.42M | Sep 28, 2022 |
| FY2021 | Jun 30, 2020 | $1.95M | Sep 28, 2021 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $7.12M | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | $5.86M | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | $9.22M | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $6.03M | Sep 29, 2023 |
| FY2022 | Jun 30, 2021 | $1.96M | Sep 28, 2022 |
| FY2021 | Jun 30, 2020 | $808.1K | Sep 28, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($2.55M) | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | ($6.39M) | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | ($28.56M) | Sep 30, 2024 |
| FY2022 | Jun 30, 2022 | $1.78M | Sep 28, 2022 |
| FY2022 | Jun 30, 2021 | ($6.09M) | Sep 28, 2022 |
| FY2021 | Jun 30, 2020 | ($4.99M) | Sep 28, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($2.74M) | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | ($6.62M) | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | ($28.81M) | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | ($6.34M) | Sep 29, 2023 |
| FY2022 | Jun 30, 2021 | ($5.95M) | Sep 28, 2022 |
| FY2021 | Jun 30, 2020 | ($4.92M) | Sep 28, 2021 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $3.49M | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | $5.46M | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | $8.79M | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $6.16M | Sep 29, 2023 |
| FY2022 | Jun 30, 2021 | $3.18M | Sep 28, 2022 |
| FY2021 | Jun 30, 2020 | $2.43M | Sep 28, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($273.8K) | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | ($5.21M) | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | ($9.16M) | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | ($4.94M) | Sep 29, 2023 |
| FY2022 | Jun 30, 2021 | ($1.21M) | Sep 28, 2022 |
| FY2021 | Jun 30, 2020 | ($2.02M) | Sep 28, 2021 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $42.5K | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | $31.5K | Sep 29, 2025 |
| FY2022 | Jun 30, 2022 | $202.0K | Sep 28, 2022 |
| FY2022 | Jun 30, 2021 | $28.0K | Sep 28, 2022 |
| FY2021 | Jun 30, 2020 | $32.7K | Sep 28, 2021 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $19.28M | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | $15.56M | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | $24.28M | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $38.40M | Sep 29, 2023 |
| FY2022 | Jun 30, 2021 | $3.22M | Sep 28, 2022 |
| FY2021 | Jun 30, 2020 | $2.00M | Sep 28, 2021 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $2.34M | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | $4.02M | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | $13.05M | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $9.58M | Sep 29, 2023 |
| FY2022 | Jun 30, 2021 | $4.39M | Sep 28, 2022 |
| FY2021 | Jun 30, 2020 | $2.30M | Sep 28, 2021 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $16.94M | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | $11.54M | Sep 29, 2025 |
| FY2025 | Jun 30, 2023 | $11.22M | Sep 29, 2025 |
| FY2024 | Jun 30, 2022 | $28.82M | Sep 30, 2024 |
| FY2023 | Jun 30, 2021 | ($1.17M) | Sep 29, 2023 |
| FY2022 | Jun 30, 2020 | ($305.7K) | Sep 28, 2022 |
| FY2021 | Jun 30, 2019 | $1.47M | Sep 28, 2021 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $10.86M | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | $10.86M | Sep 29, 2025 |
| FY2025 | Jun 30, 2023 | $11.24M | Sep 29, 2025 |
| FY2024 | Jun 30, 2022 | $13.46M | Sep 30, 2024 |
| FY2021 | Jun 30, 2021 | $0 | Sep 28, 2021 |
| FY2021 | Jun 30, 2020 | $0 | Sep 28, 2021 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($65.59M) | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | ($63.04M) | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | ($56.64M) | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | ($28.08M) | Sep 29, 2023 |
| FY2022 | Jun 30, 2021 | ($22.12M) | Sep 28, 2022 |
| FY2021 | Jun 30, 2020 | ($16.02M) | Sep 28, 2021 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $6.83M | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | $1.85M | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | $5.62M | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $16.25M | Sep 29, 2023 |
| FY2022 | Nov 30, 2021 | $11.50M | Sep 28, 2022 |
| FY2022 | Jun 30, 2021 | $1.77M | Sep 28, 2022 |
| FY2021 | Jun 30, 2020 | $1.03M | Sep 28, 2021 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 0 | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | 0 | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | (2) | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | 0 | Sep 29, 2023 |
| FY2022 | Jun 30, 2021 | 0 | Sep 28, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 0 | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | 0 | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | (2) | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | 0 | Sep 29, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 21.06M | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | 18.16M | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | 14.70M | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | 12.75M | Sep 29, 2023 |
| FY2022 | Jun 30, 2021 | 7.58M | Sep 28, 2022 |
| FY2021 | Jun 30, 2020 | 7.04M | Sep 28, 2021 |